[go: up one dir, main page]

FR2865735B1 - INHIBITORS OF ANGIOGENESIS, COMPOSITIONS CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEREGULATION OF ANGIOGENESIS - Google Patents

INHIBITORS OF ANGIOGENESIS, COMPOSITIONS CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEREGULATION OF ANGIOGENESIS

Info

Publication number
FR2865735B1
FR2865735B1 FR0400964A FR0400964A FR2865735B1 FR 2865735 B1 FR2865735 B1 FR 2865735B1 FR 0400964 A FR0400964 A FR 0400964A FR 0400964 A FR0400964 A FR 0400964A FR 2865735 B1 FR2865735 B1 FR 2865735B1
Authority
FR
France
Prior art keywords
angiogenesis
deregulation
inhibitors
treatment
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0400964A
Other languages
French (fr)
Other versions
FR2865735A1 (en
Inventor
Daniele Mathieu
Jamal Temsamani
Michel Kaczorek
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Synt EM SA
Original Assignee
Synt EM SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synt EM SA filed Critical Synt EM SA
Priority to FR0400964A priority Critical patent/FR2865735B1/en
Priority to FR0405954A priority patent/FR2865736B1/en
Priority to US10/587,874 priority patent/US20070161553A1/en
Priority to PCT/FR2005/000222 priority patent/WO2005075509A1/en
Priority to AU2005210063A priority patent/AU2005210063A1/en
Priority to EP05717534A priority patent/EP1711521A1/en
Priority to CA002554822A priority patent/CA2554822A1/en
Priority to JP2006550249A priority patent/JP2008505848A/en
Publication of FR2865735A1 publication Critical patent/FR2865735A1/en
Application granted granted Critical
Publication of FR2865735B1 publication Critical patent/FR2865735B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0400964A 2004-02-02 2004-02-02 INHIBITORS OF ANGIOGENESIS, COMPOSITIONS CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEREGULATION OF ANGIOGENESIS Expired - Fee Related FR2865735B1 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR0400964A FR2865735B1 (en) 2004-02-02 2004-02-02 INHIBITORS OF ANGIOGENESIS, COMPOSITIONS CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEREGULATION OF ANGIOGENESIS
FR0405954A FR2865736B1 (en) 2004-02-02 2004-06-02 INHIBITORS OF ANGIOGENESIS, COMPOSITIONS CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEREGULATION OF ANGIOGENESIS
PCT/FR2005/000222 WO2005075509A1 (en) 2004-02-02 2005-02-02 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation
AU2005210063A AU2005210063A1 (en) 2004-02-02 2005-02-02 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation
US10/587,874 US20070161553A1 (en) 2004-02-02 2005-02-02 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation
EP05717534A EP1711521A1 (en) 2004-02-02 2005-02-02 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation
CA002554822A CA2554822A1 (en) 2004-02-02 2005-02-02 Angiogenesis inhibitors, compositions containing same and use thereof for treating diseases related to angiogenetic deregulation
JP2006550249A JP2008505848A (en) 2004-02-02 2005-02-02 Angiogenesis inhibitors, compositions containing them and their use in the treatment of diseases associated with angiogenesis disorders

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0400964A FR2865735B1 (en) 2004-02-02 2004-02-02 INHIBITORS OF ANGIOGENESIS, COMPOSITIONS CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEREGULATION OF ANGIOGENESIS

Publications (2)

Publication Number Publication Date
FR2865735A1 FR2865735A1 (en) 2005-08-05
FR2865735B1 true FR2865735B1 (en) 2006-08-11

Family

ID=34746365

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0400964A Expired - Fee Related FR2865735B1 (en) 2004-02-02 2004-02-02 INHIBITORS OF ANGIOGENESIS, COMPOSITIONS CONTAINING SAME AND USE THEREOF FOR THE TREATMENT OF DISEASES ASSOCIATED WITH DEREGULATION OF ANGIOGENESIS

Country Status (1)

Country Link
FR (1) FR2865735B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5562999A (en) * 1998-08-14 2000-03-06 President And Fellows Of Harvard College Methods of modulating of angiogenesis
FR2810985B1 (en) * 2000-07-03 2004-12-24 Synt Em AMPHIPATHIC LINEAR PEPTIDES AND COMPOSITIONS CONTAINING THEM

Also Published As

Publication number Publication date
FR2865735A1 (en) 2005-08-05

Similar Documents

Publication Publication Date Title
EP1799269A4 (en) OLIGORIBONUCLEOTIDES AND METHODS OF USE THEREOF FOR THE TREATMENT OF ALOPECIA, ACUTE RENAL FAILURE AND OTHER DISEASES
MA27334A1 (en) USE OF IKB KINASE INHIBITORS IN THE TREATMENT OF PAIN
EP1628530A4 (en) METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF SEPSIA
TN2010000068A1 (en) Anticorps anti-cd37
FR13C0029I2 (en) COMPOSITIONS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS
MA25820A1 (en) COMBINATIONS OF DIPEPTIDYL PEPTIDASE IV INHIBITORS AND OTHER ANTIDIABETIC AGENTS FOR THE TREATMENT OF DIABETES MELLITUS.
EP1881823A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISORDERS
EP1631269A4 (en) METHODS AND COMPOSITIONS FOR THE ADMINISTRATION OF CATECHOLIC BUTANAS FOR THE TREATMENT OF OBESITY
FR2833490B1 (en) COSMETIC USE OF AT LEAST ONE HYDROPHOBIN FOR THE TREATMENT OF KERATINIC MATERIALS AND COMPOSITIONS IMPLEMENTED
FR22C1033I1 (en) Use of dihydroimidazolones for the treatment of dogs
EP1771201A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OR PREVENTION OF OXALATE-RELATED DISEASE
EP1311261A4 (en) MEDICAMENTS FOR THE CHEMOTHERAPEUTIC TREATMENT OF DISEASES
DE60123238D1 (en) COMPOSITIONS FOR THE TREATMENT OF AUTOIMMUNE DISEASES
MA29030B1 (en) 2-ALCOXY-3,4,5-TRIHYDROXY-ALKYLAMIDES, PREPARATION THEREOF, COMPOSITIONS CONTAINING SAME AND USE THEREOF
EP2010572A4 (en) COMPOSITIONS CONTAINING HPV POLYPEPTIDES AND IMMUNOSTIMULATION PEPTIDES FOR THE TREATMENT AND PREVENTION OF CERVICAL CANCER
FR2869540B1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING B-CARBOLINE DERIVATIVES AND THEIR USE FOR THE TREATMENT OF CANCER
EP1804787A4 (en) FLAVONOID COMPOSITION FOR THE TREATMENT OF BUCCO-DENTAL DISEASES
EP1664011A4 (en) OPHTHALMIC COMPOSITIONS FOR THE TREATMENT OF OCULAR HYPERTENSION
EE200200590A (en) Use of Bradycardial Agents for the Treatment of Hypertrophic Myocardial Diseases and Novel Combinations
SE0302304D0 (en) Novel compounds
FR2860154B1 (en) COMPOSITION FOR THE TREATMENT OF MALE BREATH
EP1830873A4 (en) GLYPONECTIN (ADIPONECTIN GLYCOSYLE) FOR THE TREATMENT OF DISEASES AND CONDITIONS
MA26899A1 (en) PREPARATIONS CONTAINING A GLUCOCORTICOID MEDICAMENT FOR THE TREATMENT OF BRONCHOPULMONARY DISEASES.
FR2857597B1 (en) USE OF PEPTIDE CONJUGATES FOR THE PREPARATION OF COMPOSITIONS FOR THE PREVENTIVE AND CURATIVE TREATMENT OF ALOPECIA.
EP1359885A4 (en) INHIBITORS OF NOS FOR THE TREATMENT OF WRINKLES

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20101029